Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mature Dendritic Cell Vaccination Against Mutated Antigens in Patients With Advanced Melanoma

NCT03092453 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03092453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mature Dendritic Cell Vaccination Against Mutated Antigens in Patients With Advanced Melanoma
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Completed
Start date
May 1, 2017
Completion date
March 31, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma